Company Biography
Cytiva is a global provider of technologies and services that help advance and accelerate the development and manufacture of therapeutics. Cytiva brings speed, efficiency and capacity to research and manufacturing workflows, enabling the delivery of transformative medicines to patients.
Robust analytical control strategy with information-rich technologies
Therapeutic proteins, monoclonal antibodies (mAbs), bispecific antibodies, and antibody-drug conjugates are all large complex molecules that require robust and reliable methods for analysis and in-depth characterization. Cytiva offers tools for analysis of protein size and purity, host cell protein (HCP) impurity detection and analysis, and drug potency and comparability. Our analysis tools each have the potential to significantly improve drug product characterization and quality control to increase productivity.
Technical seminar (Pre-Recorded Presentation tab on symposium portal):
SPR applications for characterization and QC of viral vectors in crude samples
Fredrik Sundberg, Global Director Strategic Technologies at Cytiva
Related Products
Contact Information
Team Members
Qi Ao
Robyn Stoller
Phil Beckett
Michael Murphy
Allison Champagne